Hopi Health Care Center | |
Highway 264, Milepost 388, Polacca, Arizona 86042 | |
(928) 737-6000 | |
Not Available |
Name | Hopi Health Care Center |
---|---|
Type | Critical Access Hospital |
Location | Highway 264, Milepost 388, Polacca, Arizona |
Ownership | Tribal |
Emergency Services | No |
Medicare ID (CCN) | 031305 |
NPI Number | 1184998635 |
Organization Name | DHHS IHS PHOENIX AREA |
Doing Business As | HOPI HEALTH CARE CENTER |
Address | Highway 264 Milepost 388, Polacca, AZ 86042 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 928-737-6000 |
News Archive
AgeneBio, a biopharmaceutical company developing innovative therapeutics for unserved patients battling neurodegeneration, announced today that its HOPE4MCI Phase 3 clinical trial has received support from the National Institutes of Health.
Experiences of loneliness and social isolation can lead to increased health care use among older adults, according to new research from the University of Georgia College of Public Health.
A landmark trial showed that the replacement of the standard malaria drug Quinine with the newer drug Artesunate for children with severe malaria could save 100,000 lives a year. The World Health Organisation (WHO) recommended that artesunate derived from a Chinese plant called sweet wormwood, replace the four-century-old remedy of quinine for treating severe malaria in adults in 2006. Similar recommendations were not made for children with further trial results pending.
One of the problems facing medical practitioners in emerging countries is the shortage of basic health infrastructures for effectively diagnosing diseases and administering treatments. SANAR, an online platform developed by Albert Moreira, a Universidad Politécnica de Madrid Facultad de Informática PhD student, aims to solve this problem. SANAR will improve information exchange among medical practitioners from different parts of the globe.
Royal Philips and Netherlands-based Radboud university medical center today introduced a connected digital health prototype that enables people living with diabetes and their health care providers to make more confident care decisions while managing the complexity of diabetes self-care. In its first phase, the solution both organizations are developing will focus on patients living with diabetes type 1.
› Verified 5 days ago
NPI Number | 1891062451 |
Organization Name | DHHS IHS PHOENIX AREA |
Doing Business As | HOPI HEALTH CARE CENTER |
Address | Highway 264 Milepost 388, Polacca, AZ 86042 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 928-737-6000 |
News Archive
AgeneBio, a biopharmaceutical company developing innovative therapeutics for unserved patients battling neurodegeneration, announced today that its HOPE4MCI Phase 3 clinical trial has received support from the National Institutes of Health.
Experiences of loneliness and social isolation can lead to increased health care use among older adults, according to new research from the University of Georgia College of Public Health.
A landmark trial showed that the replacement of the standard malaria drug Quinine with the newer drug Artesunate for children with severe malaria could save 100,000 lives a year. The World Health Organisation (WHO) recommended that artesunate derived from a Chinese plant called sweet wormwood, replace the four-century-old remedy of quinine for treating severe malaria in adults in 2006. Similar recommendations were not made for children with further trial results pending.
One of the problems facing medical practitioners in emerging countries is the shortage of basic health infrastructures for effectively diagnosing diseases and administering treatments. SANAR, an online platform developed by Albert Moreira, a Universidad Politécnica de Madrid Facultad de Informática PhD student, aims to solve this problem. SANAR will improve information exchange among medical practitioners from different parts of the globe.
Royal Philips and Netherlands-based Radboud university medical center today introduced a connected digital health prototype that enables people living with diabetes and their health care providers to make more confident care decisions while managing the complexity of diabetes self-care. In its first phase, the solution both organizations are developing will focus on patients living with diabetes type 1.
› Verified 5 days ago
NPI Number | 1922455013 |
Organization Name | HOPI HEALTH CARE CENTER |
Address | Hwy 264, Mp 388, Polacca, AZ 86042 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 928-737-8000 |
News Archive
AgeneBio, a biopharmaceutical company developing innovative therapeutics for unserved patients battling neurodegeneration, announced today that its HOPE4MCI Phase 3 clinical trial has received support from the National Institutes of Health.
Experiences of loneliness and social isolation can lead to increased health care use among older adults, according to new research from the University of Georgia College of Public Health.
A landmark trial showed that the replacement of the standard malaria drug Quinine with the newer drug Artesunate for children with severe malaria could save 100,000 lives a year. The World Health Organisation (WHO) recommended that artesunate derived from a Chinese plant called sweet wormwood, replace the four-century-old remedy of quinine for treating severe malaria in adults in 2006. Similar recommendations were not made for children with further trial results pending.
One of the problems facing medical practitioners in emerging countries is the shortage of basic health infrastructures for effectively diagnosing diseases and administering treatments. SANAR, an online platform developed by Albert Moreira, a Universidad Politécnica de Madrid Facultad de Informática PhD student, aims to solve this problem. SANAR will improve information exchange among medical practitioners from different parts of the globe.
Royal Philips and Netherlands-based Radboud university medical center today introduced a connected digital health prototype that enables people living with diabetes and their health care providers to make more confident care decisions while managing the complexity of diabetes self-care. In its first phase, the solution both organizations are developing will focus on patients living with diabetes type 1.
› Verified 5 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
AgeneBio, a biopharmaceutical company developing innovative therapeutics for unserved patients battling neurodegeneration, announced today that its HOPE4MCI Phase 3 clinical trial has received support from the National Institutes of Health.
Experiences of loneliness and social isolation can lead to increased health care use among older adults, according to new research from the University of Georgia College of Public Health.
A landmark trial showed that the replacement of the standard malaria drug Quinine with the newer drug Artesunate for children with severe malaria could save 100,000 lives a year. The World Health Organisation (WHO) recommended that artesunate derived from a Chinese plant called sweet wormwood, replace the four-century-old remedy of quinine for treating severe malaria in adults in 2006. Similar recommendations were not made for children with further trial results pending.
One of the problems facing medical practitioners in emerging countries is the shortage of basic health infrastructures for effectively diagnosing diseases and administering treatments. SANAR, an online platform developed by Albert Moreira, a Universidad Politécnica de Madrid Facultad de Informática PhD student, aims to solve this problem. SANAR will improve information exchange among medical practitioners from different parts of the globe.
Royal Philips and Netherlands-based Radboud university medical center today introduced a connected digital health prototype that enables people living with diabetes and their health care providers to make more confident care decisions while managing the complexity of diabetes self-care. In its first phase, the solution both organizations are developing will focus on patients living with diabetes type 1.
› Verified 5 days ago
Hopi Health Care Center Critical Access Hospital Location: Highway 264, Milepost 388, Polacca, Arizona 86042 Phone: (928) 737-6000 |